Invention Grant
- Patent Title: FSH glycosylation variant D3N
- Patent Title (中): FSH糖基化变体D3N
-
Application No.: US12158539Application Date: 2007-01-16
-
Publication No.: US07956034B2Publication Date: 2011-06-07
- Inventor: Marco Muda , Xuliang Jiang , Sean D. McKenna
- Applicant: Marco Muda , Xuliang Jiang , Sean D. McKenna
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Saliwanchik, Lloyd & Eisenschenk
- International Application: PCT/US2007/001004 WO 20070116
- International Announcement: WO2007/084441 WO 20070726
- Main IPC: A61K38/24
- IPC: A61K38/24 ; A61K39/00 ; A61K39/385 ; C12N5/00 ; C12N15/09 ; C12N5/07

Abstract:
FSH mutant with increased glycosylation and longer half-life is described. The use of this FSH mutant for inducing folliculogenesis in human patients is also described.
Public/Granted literature
- US20080280832A1 Novel Fsh Glycosylation Variant D3n Public/Granted day:2008-11-13
Information query
IPC分类: